Literature DB >> 17620296

The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.

Sheela Onnockx1, Julie De Schutter, Marianne Blockmans, Jingwei Xie, Christine Jacobs, Jean-Marie Vanderwinden, Christophe Erneux, Isabelle Pirson.   

Abstract

SHIP2 (SH2-containing inositol polyphosphate 5-phosphatase 2) is a phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P(3)) 5-phosphatase containing various motifs susceptible to mediate protein-protein interaction. In cell models, SHIP2 negatively regulates insulin signalling through its catalytic PtdIns(3,4,5)P(3) 5-phosphatase activity. We have previously reported that SHIP2 interacts with the c-Cbl associated protein (CAP) and c-Cbl, proteins implicated in the insulin cellular response regulating the small G protein TC10. The first steps of the TC10 pathway are the recruitment and tyrosine phosphorylation by the insulin receptor of the adaptor protein with Pleckstrin Homology and Src Homology 2 domains (APS). Herein, we show that SHIP2 can directly interact with APS in 3T3-L1 adipocytes and in transfected CHO-IR cells (Chinese hamster ovary cells stably transfected with the insulin receptor). Upon insulin stimulation, APS and SHIP2 are recruited to cell membranes as seen by immunofluorescence studies, which is consistent with their interaction. We also observed that SHIP2 negatively regulates APS insulin-induced tyrosine phosphorylation and consequently inhibits APS association with c-Cbl. APS, which specifically interacts with SHIP2, but not PTEN, in turn, increases the PtdIns(3,4,5)P(3) 5-phosphatase activity of SHIP2 in an inositol phosphatase assay. Co-transfection of SHIP2 and APS in CHO-IR cells further increases the inhibitory effect of SHIP2 on Akt insulin-induced phosphorylation. Therefore, the interaction between APS and SHIP2 provides to both proteins potential negative regulatory mechanisms to act on the insulin cascade. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17620296     DOI: 10.1002/jcp.21193

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

Review 1.  SH2B1 regulation of energy balance, body weight, and glucose metabolism.

Authors:  Liangyou Rui
Journal:  World J Diabetes       Date:  2014-08-15

2.  Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.

Authors:  Parvin Rahman; Richard D Huysmans; Fenny Wiradjaja; Rajendra Gurung; Lisa M Ooms; David A Sheffield; Jennifer M Dyson; Meredith J Layton; Absorn Sriratana; Hidetoshi Takada; Tony Tiganis; Christina A Mitchell
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

3.  The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus.

Authors:  Shannon McNulty; Kimberly Powell; Christophe Erneux; Daniel Kalman
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

4.  SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

Authors:  Julie De Schutter; Aude Guillabert; Virginie Imbault; Chantal Degraef; Christophe Erneux; David Communi; Isabelle Pirson
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

5.  Variegation and silencing in a lentiviral-based murine transgenic model.

Authors:  Delphine Baup; Laurent Fraga; Eileen Pernot; Annette Van Acker; Anne-Sophie Vanherck; Karine Breckpot; Kris Thielemans; Stéphane Schurmans; Muriel Moser; Oberdan Leo
Journal:  Transgenic Res       Date:  2009-08-23       Impact factor: 2.788

6.  Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.

Authors:  Matthew D Blunt; Stephen G Ward
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

7.  Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.

Authors:  Kenneth Siddle
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-28       Impact factor: 5.555

8.  Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.

Authors:  Elmer Hoekstra; Asha M Das; Marcella Willemsen; Marloes Swets; Peter J K Kuppen; Christien J van der Woude; Marco J Bruno; Jigisha P Shah; Timo L M Ten Hagen; John D Chisholm; William G Kerr; Maikel P Peppelenbosch; Gwenny M Fuhler
Journal:  Oncotarget       Date:  2016-11-08

Review 9.  Ubiquitin-like processing of TUG proteins as a mechanism to regulate glucose uptake and energy metabolism in fat and muscle.

Authors:  Jonathan S Bogan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.